Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound
Current Issues in Molecular Biology · 29.05.2025 · 47 (6) · 402
DOI: 10.3390/cimb47060402 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.05.2025. Verfasst von Iliya Mangarov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, University Hospital "SofiaMed", Faculty of Medicine, Sofia University, St. Kliment Ohridski, 1504 Sofia, Bulgaria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 305 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Sofia and the European Union—NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria.
Abstract (Originalsprache)
Alpha-lipoic acid (ALA, also known as thioctic acid) was discovered nearly 90 years ago and began to be used in clinical practice in the late 1950s. Numerous nonclinical and clinical studies have investigated ALA for treating diabetic peripheral neuropathy (DPN) and various other diseases. The rising global prevalence of DPN necessitates timely treatment; however, there is currently no effective cure. Current guideline-recommended therapies for DPN provide symptom relief rather than modifying the disease. Among the pathogenesis-oriented therapies, ALA holds a unique position as a universal antioxidant, essential for every cell in the body. This review highlights the ongoing issues and challenges in using ALA to treat DPN. While confronting a complex disease with poorly understood pathophysiology, we also have an endogenous substance with pleiotropic effects on all cells in the human body. It becomes clear that this is a highly multifactorial process that will likely never be precisely defined. This does not diminish the significance of ALA in treating DPN but underscores the need for a deeper understanding of when to start therapy, dosage, duration, and monitoring. In this comprehensive review, we evaluate the achievements of the past 70 years and highlight gaps in ALA’s role in treating DPN.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology, University Hospital "SofiaMed", Faculty of Medicine, Sofia University, St. Kliment Ohridski, 1504 Sofia, Bulgaria.
- Department of Chemistry, Faculty of Pharmacy, Medical University, 1000 Sofia, Bulgaria.
- Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
- Independent Researcher, 1680 Sofia, Bulgaria.
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
ORCID-Profile: Iliya Mangarov, Valentina Petkova, Lyubomir Marinov
Förderung
- Medical University of Sofia and the European Union—NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria
Zitieren
APA
Mangarov, I., Voynikov, Y., Petkova, V., Iliev, S., Kostadinova, I., Marinov, L., & Nikolova, I. (2025). Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound. Current Issues in Molecular Biology, 47(6), 402. https://doi.org/10.3390/cimb47060402
Vancouver
Mangarov I, Voynikov Y, Petkova V, Iliev S, Kostadinova I, Marinov L, et al. Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound. Current Issues in Molecular Biology. 2025;47(6):402. doi:10.3390/cimb47060402
BibTeX
@article{Mangarov2025,
author = {Mangarov, Iliya and Voynikov, Yulian and Petkova, Valentina and Iliev, Simeon and Kostadinova, Ivanka and Marinov, Lyubomir and Nikolova, Irina},
title = {Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {6},
pages = {402},
doi = {10.3390/cimb47060402}
}
EUVIMED